Have you ever noticed how a solid eight hours of sleep feels like a distant memory as you get older? You’re not alone.
What happens when a promising therapy falls short? Medscape spoke with Jeffrey Cummings, MD, who led the EVOKE trials of the GLP-1 semaglutide for AD, about what the results mean — and what comes next ...
Study of 600,000 US military veterans shows that those who took anti-obesity medications were less likely to develop some complications of substance-use disorders.
New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.
Stories about celebrities taking propanolol, a beta-blocking drug, are all over the place. It's being used to ward off stage fright. Does it really work, or is it just more celebrity nonsense? Hint - ...
Post-traumatic stress disorder (PTSD) is not only characterized by strongly encoded traumatic memories, but also by disrupted coordination across brain networks.
A new study finds that popular GLP-1 drugs used to treat diabetes and obesity show new promise in fighting multiple substance use disorders ...
New research reveals that psilocybin and MDMA promote long-term PTSD recovery by physically remodeling myelin insulation in the brain, synchronizing disrupted neural circuits.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results